January 7, 2025 - 23:04

HOUSTON, January 07, 2025—Corebridge Financial, Inc. has announced the appointment of Polly Klane as the new General Counsel, effective February. In her role, Klane will report directly to Chief Executive Officer Kevin Hogan and will be responsible for overseeing the company’s legal, compliance, regulatory, corporate secretary, and government affairs functions.
Klane's extensive experience in the legal sector positions her well to contribute to Corebridge's strategic objectives. She will also join the Executive Leadership Team, where her insights will help shape the company's direction and governance. This transition follows the retirement of Christine Nixon, who held the General Counsel position and announced her departure last year after a distinguished career with the company.
Klane’s appointment signals Corebridge's commitment to strengthening its legal framework and enhancing its compliance measures as it navigates the complexities of the financial landscape. The company looks forward to her leadership and expertise in fostering a robust legal environment.
September 12, 2026 - 00:50
US Tariff Refunds Slow as Government Collects More Than It Pays OutThe flow of tariff refunds from the US government has slowed sharply, with new figures showing the Treasury took in more money from tariffs than it returned to importers for the first time in...
September 11, 2026 - 02:46
Rayonier Advanced Materials’ (RYAM) Pricing Power Is Surging, But Volumes Tell Another StoryRayonier Advanced Materials reported second-quarter results on August 4 for the period ending June 27, showing a mixed picture of financial performance. Net sales reached $376 million, an 18...
September 10, 2026 - 21:54
OpenAI Rolls Out ChatGPT for Financial Services With Major Industry PartnersOpenAI has introduced a version of ChatGPT built specifically for the financial sector, teaming up with several large brokerages and research organizations, including Morgan Stanley and S&P. The...
September 10, 2026 - 04:58
InMed Reports Full Year Fiscal 2026 Financial Results and Provides Corporate UpdateVancouver-based InMed Pharmaceuticals has released its financial results for the full fiscal year that ended on June 30, 2026, alongside a broader update on its corporate activities. The company,...